Matches in Nanopublications for { ?s ?p "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 17 of
17
with 100 items per page.
- NP534062.RA_Rq0viVSIzOn7y0A3oE_E-lFHEjmsLMqzjjT6BexsC8130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534062.RA_Rq0viVSIzOn7y0A3oE_E-lFHEjmsLMqzjjT6BexsC8130_provenance.
- assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP741279.RAV3Lbrcgr-TQR799khrniVv0fwTOsDYkifs6ojpQDzVc130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741279.RAV3Lbrcgr-TQR799khrniVv0fwTOsDYkifs6ojpQDzVc130_provenance.
- assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP62333.RAkq7-QtEYyOMIv1mljhWDVBW-25PBq8i4g3hnvUq1Goo130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62333.RAkq7-QtEYyOMIv1mljhWDVBW-25PBq8i4g3hnvUq1Goo130_provenance.
- NP57003.RAAgwmPnqdab3CktmkyYc4Hi1XTRvDi81ZNkXgghpTZ-c130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP57003.RAAgwmPnqdab3CktmkyYc4Hi1XTRvDi81ZNkXgghpTZ-c130_provenance.
- assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP849470.RAa7Se-TbamqK1E5NAY5hw7jZDeaAcqWMUuBnEV6yPjBQ130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849470.RAa7Se-TbamqK1E5NAY5hw7jZDeaAcqWMUuBnEV6yPjBQ130_provenance.
- NP586047.RAs5l5fD-qzHxpyoSYDk0FG3WtfC-ts4CcOW1cm6jl67E130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586047.RAs5l5fD-qzHxpyoSYDk0FG3WtfC-ts4CcOW1cm6jl67E130_provenance.
- NP849472.RAlv_5Wc5D-CfUGYEUXHDAzW8JWgjaT8VcULpWZ_Zu0Fs130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849472.RAlv_5Wc5D-CfUGYEUXHDAzW8JWgjaT8VcULpWZ_Zu0Fs130_provenance.
- NP289989.RA2aBK15-tER-3_TkGUx4fIioTHmApEy3f6_5WYKIYAc8130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289989.RA2aBK15-tER-3_TkGUx4fIioTHmApEy3f6_5WYKIYAc8130_provenance.
- NP187785.RAPqyvBtBrLZfQxtxxli4v4U-BvUxPggDtGMm0lm-5myo130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187785.RAPqyvBtBrLZfQxtxxli4v4U-BvUxPggDtGMm0lm-5myo130_provenance.
- NP187787.RAHC2srY4ui8GDTmtp7qmxb17bbVEHFSyrwP1Yl-K_VBA130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187787.RAHC2srY4ui8GDTmtp7qmxb17bbVEHFSyrwP1Yl-K_VBA130_provenance.
- NP849473.RANwj4EycqLR-1ZRjwMbSGOuFGYjQ04taN5BIZfNTj2_Y130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849473.RANwj4EycqLR-1ZRjwMbSGOuFGYjQ04taN5BIZfNTj2_Y130_provenance.
- NP849471.RA2H2dlI3b6HXk8VypzSNmcW4hER3TK3Bbet5ylHf3JzQ130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849471.RA2H2dlI3b6HXk8VypzSNmcW4hER3TK3Bbet5ylHf3JzQ130_provenance.
- NP187786.RA4JHmATHd838b7e-dBFyU4ayvDd1mF_dVJW7D5rbtUk0130_assertion description "[NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187786.RA4JHmATHd838b7e-dBFyU4ayvDd1mF_dVJW7D5rbtUk0130_provenance.